MedTrace Logo

Use of New Supraglottic Airway Devices in Severely Obese Patients: A Feasibility Study

NCT01124825 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2012-11-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether two new airway devices used during anesthesia called iGEL™ and KING-LTS-DTM work well and are safe in obese patients. They both work well in thin patients, but have not been tested in obese patients.

Conditions

Interventions

DEVICE

IGEL

iGEL(TM) airway will be used for induction and maintenance of positive pressure ventilation

DEVICE

King airway

KING-LTS-D(TM) airway will be used for induction and maintenance of positive pressure ventilation

Sponsors & Collaborators

  • University of Louisville

    lead OTHER

Principal Investigators

  • Detlef Obal, MD · University of Louisville

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-05-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01124825 on ClinicalTrials.gov